Trademark: FORTITUDE 2322731
Word
FORTITUDE
ID
2322731
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
16 December 2022
Registration Date
16 December 2022
Renewal Date
16 December 2032
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 5:
Oligonucleotide-conjugate based therapeutic preparations, oligonucleotide-antibody conjugate based therapeutic preparations, and oligonucleotide-antibody fragment conjugate based therapeutic preparations including for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Oligonucleotide-conjugate based therapeutic preparations, oligonucleotide-antibody conjugate based therapeutic preparations, and oligonucleotide-antibody fragment conjugate based therapeutic preparations including for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Class 42:
Conducting clinical trials in the fields of pharmaceuticals and biotechnology, including, conducting clinical trials for the for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing medical and scientific research information including in the fields of pharmaceuticals and biotechnology; medical and scientific research, including, conducting clinical trials for oligonucleotide-based therapeutics
Conducting clinical trials in the fields of pharmaceuticals and biotechnology, including, conducting clinical trials for the for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing medical and scientific research information including in the fields of pharmaceuticals and biotechnology; medical and scientific research, including, conducting clinical trials for oligonucleotide-based therapeutics